Cascadian Therapeutics, Inc. Contracts & Agreements

Lease Termination Agreement between Selig Holdings Company and Cascadian Therapeutics, Inc., dated December 4, 2017 (Filed With SEC on March 8, 2018)

Sublease between CTI Biopharma, Corp. and Cascadian Therapeutics, Inc., dated December 4, 2017 (Filed With SEC on March 8, 2018)

Amendment to Scott Myers Confidentiality Agreement (Filed With SEC on February 7, 2018)

Form of Amendment to Employee Confidentiality, Invention Assignment and Non-Compete Agreements (Filed With SEC on February 7, 2018)

Amendment to Scott Myers Employment Agreement (Filed With SEC on February 7, 2018)

Form of Amendment to Executive Employment Agreements (Filed With SEC on February 7, 2018)

Form of Transaction Bonus Agreement (Filed With SEC on February 7, 2018)

Agreement and Plan of Merger, dated January 30, 2018, by and among the Company, Seattle Genetics, Inc. and Valley Acquisition Sub, Inc (Filed With SEC on January 31, 2018)

SEE REVERSE SIDE FOR RESTRICTIVE LEGEND(S) (Filed With SEC on January 27, 2017)

23,182,000 Shares CASCADIAN THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2017)

1,818 Shares CASCADIANTHERAPEUTICS, INC. Series E Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2017)

CASCADIAN THERAPEUTICS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES E CONVERTIBLEPREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on January 24, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 24, 2017)

2016 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on August 8, 2016)

2016 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (EMPLOYEE) (Filed With SEC on August 8, 2016)

2016 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (NON-EMPLOYEE DIRECTOR) (Filed With SEC on August 8, 2016)

SEE REVERSE SIDE FOR RESTRICTIVE LEGEND(S) (Filed With SEC on June 28, 2016)

35,000,000 Shares CASCADIAN THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 23, 2016)

17,250 Shares CASCADIAN THERAPEUTICS, INC. Series D Convertible Preferred Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on June 23, 2016)

CASCADIAN THERAPEUTICS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES D CONVERTIBLEPREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on June 23, 2016)

SUBSCRIPTION AGREEMENT (Filed With SEC on June 23, 2016)

ONCOTHYREON INC. $50,000,000 SALESAGREEMENT (Filed With SEC on June 2, 2016)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 19, 2016)

MUTUAL TERMINATION AGREEMENT Between STC.UNM ANDONCOTHYREON INC. (Filed With SEC on May 9, 2016)

RELEASE You Are Advised to Consult with an Attorney Before Signing this Release of Claims (Filed With SEC on April 1, 2016)

[SIGNATURE PAGE TO AGREEMENT] (Filed With SEC on March 29, 2016)

NOTICE OF INDUCEMENT STOCK OPTION GRANT (Filed With SEC on March 29, 2016)

ONCOTHYREON INC. AMENDMENT NO. 2 TO DIANA HAUSMAN OFFER LETTER (Filed With SEC on March 14, 2016)

THIRD AMENDMENT TO PATENT LICENSE AGREEMENT between STC.UNM and ONCOTHYREON INC. (Filed With SEC on March 14, 2016)

RETIREMENT AND SEPARATION AGREEMENT (Filed With SEC on January 11, 2016)

ONCOTHYREON INC. RETENTION PLAN AdoptedEffective January 11, 2016 (Filed With SEC on January 11, 2016)

SECOND AMENDMENT TO PATENT LICENSE AGREEMENT between STC.UNM and ONCOTHYREON INC. (Filed With SEC on November 5, 2015)

SEE REVERSE SIDE FOR RESTRICTIVE LEGEND(S) (Filed With SEC on May 14, 2015)

ONCOTHYREON INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on May 14, 2015)

FIRST AMENDMENT TO PATENT LICENSE AGREEMENT between STC.UNM and ONCOTHYREONINC. (Filed With SEC on May 11, 2015)

EXCLUSIVE LICENSE ANDCOLLABORATION AGREEMENT (Filed With SEC on May 11, 2015)

ONCOTHYREON INC. AMENDED AND RESTATED SHARE OPTION PLAN (Filed With SEC on March 10, 2015)

STOCK OPTION AGREEMENT (Filed With SEC on March 10, 2015)

LICENSEAGREEMENT (Filed With SEC on March 10, 2015)

SEE REVERSE SIDE FOR RESTRICTIVE LEGEND(S) (Filed With SEC on February 11, 2015)

13,500,000 Shares ONCOTHYREON INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2015)

1,333 Shares ONCOTHYREON INC. Series B Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2015)

ONCOTHYREON INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLEPREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL... (Filed With SEC on February 6, 2015)

ONCOTHYREON INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on February 6, 2015)

ONCOTHYREON INC. AMENDMENT NO. 2 TO SCOTT PETERSON OFFER LETTER (Filed With SEC on January 8, 2015)

ONCOTHYREON INC. PIGGYBACKREGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 6, 2014)

PATENT LICENSE AGREEMENT Between STC.UNM and ALPINE BIOSCIENCES, INC. (Filed With SEC on November 6, 2014)

SEE REVERSE SIDE FOR RESTRICTIVE LEGEND(S) (Filed With SEC on September 23, 2014)

10,000,000 Shares ONCOTHYREON INC. CommonStock UNDERWRITING AGREEMENT (Filed With SEC on September 18, 2014)

10,000 Shares ONCOTHYREON INC. SeriesA Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on September 18, 2014)

ONCOTHYREON INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLEPREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL... (Filed With SEC on September 18, 2014)

PHASE I CO-DEVELOPMENT AGREEMENT (Filed With SEC on August 11, 2014)

AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG ONCOTHYREON INC. AB ACQUISITION (DE) CORP., ALPINE BIOSCIENCES, INC. AND MITCHELL H. GOLD, M.D., AS STOCKHOLDERS AGENT AUGUST 8,... (Filed With SEC on August 11, 2014)

DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT (Filed With SEC on August 6, 2013)

FORM OF WARRANT Oncothyreon Inc. Warrant to Purchase Common Stock (Filed With SEC on May 30, 2013)

SUBSCRIPTION AGREEMENT (Filed With SEC on May 30, 2013)

11,750,000 Shares ONCOTHYREON INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 29, 2012)

ONCOTHYREON INC. AMENDED AND RESTATED SHARE OPTION PLAN (Filed With SEC on March 9, 2012)

STOCK OPTION AGREEMENT (Filed With SEC on March 9, 2012)

ONCOTHYREON INC. AMENDED AND RESTATED RESTRICTED SHARE UNIT PLAN Effective February 22, 2007, as amended and restated on June 12, 2009, October 22, 2009 and December 1, 2011 (Filed With SEC on March 9, 2012)

ONCOTHYREON INC. AMENDED AND RESTATED RESTRICTED SHARE UNIT PLAN RESTRICTED SHARE UNIT AGREEMENT (Filed With SEC on March 9, 2012)

ONCOTHYREON INC. $50,000,000 SALES AGREEMENT (Filed With SEC on February 3, 2012)

10,000,000 Shares (Filed With SEC on April 29, 2011)

identify and capitalize on possible collaboration, strategic partnering, acquisition or divestiture opportunities (Filed With SEC on March 14, 2011)

LOAN AND SECURITY AGREEMENT (Filed With SEC on February 9, 2011)

PROMISSORY NOTE (Filed With SEC on February 9, 2011)

WARRANT TO PURCHASE _________ SHARES OF COMMON STOCK (Filed With SEC on February 9, 2011)

pay in cash to the warrant holder an amount equal to such warrant holders total purchase price (including brokerage commissions, if any, that are reasonably documented in such... (Filed With SEC on October 4, 2010)

AMENDMENT NO. 1 TO THE SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 30, 2010)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 27, 2010)

ONCOTHYREON INC. (Filed With SEC on September 27, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 27, 2010)

Oncothyreon Inc.MAIN206.801.2100www.oncothyreon.comFAX ###-###-#### (Filed With SEC on August 31, 2010)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 7, 2010)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on July 7, 2010)

4510 E. Thousand Oaks Blvd Westlake Village, CA 91362 (Filed With SEC on July 7, 2010)

ONCOTHYREON INC. 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 8, 2010)

ONCOTHYREON INC. (Filed With SEC on June 8, 2010)

Cash and cash equivalents (Filed With SEC on May 10, 2010)

identify and capitalize on possible collaboration, strategic partnering, acquisition or divestiture opportunities (Filed With SEC on May 6, 2010)

ONCOTHYREON INC. AMENDMENT TO ROBERT KIRKMAN OFFER LETTER (Filed With SEC on December 7, 2009)

ONCOTHYREON INC. AMENDMENT TO GARY CHRISTIANSON OFFER LETTER (Filed With SEC on December 7, 2009)

ONCOTHYREON INC. AMENDMENT TO DIANA HAUSMAN OFFER LETTER (Filed With SEC on December 7, 2009)

ONCOTHYREON INC. AMENDMENT TO SCOTT PETERSON OFFER LETTER (Filed With SEC on December 7, 2009)

ONCOTHYREON INC. AMENDMENT TO SHASHI KARAN OFFER LETTER (Filed With SEC on December 7, 2009)

ONCOTHYREON INC. AMENDED AND RESTATED RESTRICTED SHARE UNIT PLAN Effective February22, 2007, as amended and restated on June 12, 2009 and October 22, 2009 (Filed With SEC on October 14, 2009)

ONCOTHYREON INC. AMENDED AND RESTATED SHARE OPTION PLAN (Filed With SEC on October 14, 2009)

STOCK OPTION AGREEMENT (Filed With SEC on October 14, 2009)

Oncothyreon Inc. MAIN 206.801.2100www.oncothyreon.com FAX ###-###-#### 2601 Fourth Ave., Suite 500 Seattle, WA 98121 (Filed With SEC on August 4, 2009)

ONCOTHYREONINC. AMENDEDAND RESTATED RESTRICTED SHARE UNIT PLAN RESTRICTEDSHARE UNIT AGREEMENT (Filed With SEC on June 15, 2009)

Cash and cash equivalents (Filed With SEC on May 15, 2009)

identify and capitalize on possible collaboration, strategic partnering, acquisition or divestiture opportunities (Filed With SEC on March 30, 2009)

Cash and cash equivalents (Filed With SEC on November 10, 2008)

Category

Industry

Companies

Contracts

Cascadian Therapeutics, Inc. Contracts & Agreements